within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01D_OtherBetaLactamAntibacterials.J01DD54_CeftriaxoneCombinations;

model CeftriaxoneCombinations
  extends Pharmacolibrary.Drugs.ATC.J.J01DD54;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01DD54</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ceftriaxone, in combination with other agents, is a broad-spectrum third-generation cephalosporin antibiotic. It is used for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and meningitis. It is generally administered parenterally and is approved for clinical use worldwide. The ATC code J01DD54 refers to ceftriaxone in combination, often with beta-lactamase inhibitors or similar compounds.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for ceftriaxone in combination (ATC J01DD54) are not specifically reported in the literature for combination products; therefore, the following are standard estimates based on the pharmacokinetics of ceftriaxone given intravenously in healthy adults.</p><h4>References</h4><ol><li><p>Cetin, G, et al., &amp; Uney, K (2021). Effect of ketoprofen and tolfenamic acid on intravenous pharmacokinetics of ceftriaxone in sheep. <i>Journal of veterinary pharmacology and therapeutics</i> 44(6) 945–951. DOI:<a href=&quot;https://doi.org/10.1111/jvp.13001&quot;>10.1111/jvp.13001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34312894/&quot;>https://pubmed.ncbi.nlm.nih.gov/34312894</a></p></li><li><p>Sullins, AK, &amp; Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. <i>Paediatric drugs</i> 15(2) 93–117. DOI:<a href=&quot;https://doi.org/10.1007/s40272-013-0017-5&quot;>10.1007/s40272-013-0017-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23529866/&quot;>https://pubmed.ncbi.nlm.nih.gov/23529866</a></p></li><li><p>Borner, K, et al., &amp; Koeppe, P (1985). Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration. <i>Chemotherapy</i> 31(4) 237–245. DOI:<a href=&quot;https://doi.org/10.1159/000238342&quot;>10.1159/000238342</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4028870/&quot;>https://pubmed.ncbi.nlm.nih.gov/4028870</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end CeftriaxoneCombinations;
